logo
FDA urges food manufacturers to halt use of controversial ingredients: 'Why are we taking a gamble?'

FDA urges food manufacturers to halt use of controversial ingredients: 'Why are we taking a gamble?'

Yahoo24-04-2025

The U.S. Food and Drug Administration announced it is urging food manufacturers to start reducing or eliminating the use of artificial food dyes — such as Red 40, Yellow 5 and Blue 1 — by the end of 2026. These synthetic colors are made from petroleum and are used in processed foods to create the typical bright or otherwise unnatural colors in everything from cereal to candy.
The move is part of a nonpartisan public health effort — led by organizations such as the Center for Science in the Public Interest and Consumer Reports — to cut back on ingredients that may pose health risks, especially for children. Red 3, one of the dyes under the most scrutiny in recent years, was already banned by the FDA under the Biden administration, with an effective date of January 2027, as a result of studies linking it to cancer in laboratory animals.
At the time of that ban, the FDA passed on taking action against the eight other artificial dyes used in food. A CBS report noted the FDA and Secretary of Health and Human Services Robert F. Kennedy Jr. again declined to pursue a wider ban and are instead directly asking companies to voluntarily make the switch to safer, plant-based alternatives.
The push may yield some results, but some experts said they were disappointed at the lack of stronger action.
"There was no ban, no regulation, no enforcement. Just a vague announcement and a hope that food companies might voluntarily change," said Dr. Jessica Knurick, a dietitian with a PhD in nutrition science, in an Instagram post to her 900,000 followers. "This is textbook performative politics: make a headline, say something vague, and let the internet celebrate it like a win."
While there are many alternatives for food coloring already in wide use — especially outside the U.S., where artificial food dye usage is far less common — the agency has said it will work to speed up the approval process for any new alternatives to help ease the transition. Some companies have experimented with removing artificial dyes — General Mills said Trix went back to synthetic colors after customer feedback — while many popular brands have never stopped using them.
An assessment from California's Office of Environmental Health Hazard found that synthetic food dyes can affect attention span, behavior, and learning in children. Many European countries already require food products containing certain dyes to carry warning labels, which has led to products like Froot Loops being made with a different recipe in order to avoid the label. It's a move that the U.S. could adopt to motivate companies to make the switch, though Kennedy and the FDA did not make such a promise.
"Why are we taking a gamble? Parents, moms and dads have also tried to raise attention to this issue," Food and Drug Administration head Marty Makary said in the CBS report. "Some parents have observed that these chemicals cause hyperactivity and even aggressive behavior, and that it subsides when the chemicals are removed from the diet."
Besides the direct health consequences, these dyes are made using petroleum from fossil fuels, which contribute to pollution and rising global temperatures. More natural color sources like beet juice, turmeric, and spirulina are not only safer and healthier but better for the environment, too.
"To companies that are currently using petroleum-based red dye, try watermelon juice," Makary said in a report.
If more food companies follow the FDA's lead, grocery shelves might start to look a little less colorful, but there's no reason to view that as a bad thing. For parents and shoppers trying to avoid ultra-processed foods, this change could make it easier to spot better options and make food shopping a little less complicated.
Do you worry about having toxic forever chemicals in your home?
Majorly
Sometimes
Not really
I don't know enough about them
Click your choice to see results and speak your mind.
Join our free newsletter for easy tips to save more and waste less, and don't miss this cool list of easy ways to help yourself while helping the planet.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Health New England to replace Humira coverage with lower-cost biosimilars
Health New England to replace Humira coverage with lower-cost biosimilars

Yahoo

time3 hours ago

  • Yahoo

Health New England to replace Humira coverage with lower-cost biosimilars

SPRINGFIELD, Mass. (WWLP) – Health New England announced Monday that it will shift coverage of the biologic drug Humira to more affordable FDA-approved biosimilars starting next month for members of its commercial health plans. Markey playing defense against GOP clean energy plans Effective July 1, the not-for-profit health insurer will cover Amjevita by Nuvaila and Hadlima instead of Humira, as part of a broader effort to manage rising health care costs while maintaining access to effective treatments. Humira is used to treat several chronic inflammatory conditions, including rheumatoid arthritis, Crohn's disease, and plaque psoriasis. 'Biologic medications like Humira are complex treatments that carry significant cost. Its biosimilars provide a meaningful opportunity to enhance affordability for the health care ecosystem while members continue to get the full benefits of the medication,' said Gary Tereso, PharmD, Director of Pharmacy Services at Health New England. Biologic drugs are made from living organisms and are typically more expensive than other medications. Biosimilars are developed to be nearly identical in safety, potency, and efficacy to the original biologic, but at a significantly lower cost. The shift in coverage is intended to make treatment more accessible and financially sustainable for members and employer groups alike. Health New England is directly reaching out to members who are currently prescribed Humira, along with their health care providers and pharmacies, to assist with the transition. The company said it will continue monitoring the biosimilar marketplace to ensure members receive both high-quality care and cost-effective treatment options. WWLP-22News, an NBC affiliate, began broadcasting in March 1953 to provide local news, network, syndicated, and local programming to western Massachusetts. Watch the 22News Digital Edition weekdays at 4 p.m. on Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Iris Ventures Leads Multimillion-dollar Investment Into Fast-growing Wellness Platform Healf
Iris Ventures Leads Multimillion-dollar Investment Into Fast-growing Wellness Platform Healf

Yahoo

time3 hours ago

  • Yahoo

Iris Ventures Leads Multimillion-dollar Investment Into Fast-growing Wellness Platform Healf

— Healf, a leading online retailer selling premium wellness products, has closed a multimillion-dollar funding round led by Iris Ventures, an international growth equity firm specializing in next-generation lifestyle and health-focused brands. Launched four years ago by brothers Lestat McCree and Max Clarke, Healf has become one of the U.K.'s fastest-growing well-being companies. It has built a reputation for its polished curation, clear communication and a personalized approach to well-being. More from WWD The Top Five Health and Wellness Trends in 2025, According to The Vitamin Shoppe Farfetch Pushes Into South Korea, One of the World's Biggest Luxury Markets EXCLUSIVE: Beekman 1802 Founders Release Book 'G.O.A.T. Wisdom: How to Build a Truly Great Business' The company has been able to scale quickly in what remains a fragmented market in the U.K., populated by pharmacies and retail chains that are often cluttered with product — and the opposite of aspirational. Healf has a growing community of 325,000 customers and 282,000 followers on Instagram, and is on track to post $100 million in revenue by the end of 2025. The plan is to expand Healf across Europe and capitalize on the booming wellness trend. The personal health and well-being category alone is estimated to be worth $1.8 trillion globally. Healf's approach is to help people take control of their health with a holistic approach that's focused on the basics: eating, moving, sleeping and mindfulness. The site stocks more than 4,000 curated products to tend to those needs, and helps customers personalize their approach. Healf is also packed with slick editorial images and articles on how to lower cortisol levels naturally; special massages for lymphatic health; and how to bring 'more brain-soothing beauty into your life.' Customers take surveys to help them target the best remedies, and there is also an AI assistant that doles out recommendations about gut health, sleep habits and how to manage stress and anxiety. McCree said he and Clarke started the company because 'well-being shouldn't feel overwhelming — but it so often does. From Day One, Healf has been dedicated to cutting through the noise with simplicity, credibility and curation.' He added that the company's trademarked Four Pillars strategy focused on eating, moving, sleeping and mindfulness acts as a compass, and helps the founders deliver on quality, service and product offerings. Clarke said he and his brother were inspired by their own well-being journeys and have experienced the 'tangible and synergistic benefits that accompany a holistic approach to well-being — a major unlock we believe all consumers deserve access to.' Florian Wojewodzki, partner at Iris Ventures, said 'we quickly understood that Max and Lestat were a rare breed of founders. They are mission-driven brothers exemplifying laser focus and militant execution at every turn. 'Their uncompromising pursuit of product, innovation and customer journey excellence has been a masterclass, and propelled Healf to the forefront of health and wellness disruption. The company's highly engaged and growing community is a testament to its standout offering and the consumer trust it has so deservedly earned,' Wojewodzki said. Montse Suarez, founder and managing partner of Iris Ventures, said that 'with smart retail curation, personalized tech, and habit-forming products, wellness is no longer an add-on — it's seamlessly woven into everyday life. We're seeing a powerful shift from reactive fixes to proactive strategies. 'Max and Lestat recognized this early on and, with unwavering focus on excellence, have rapidly built an exceptional business. We're proud to partner with them and to help shape the future of well-being together,' she said. Iris Ventures is a thematic fund targeting European, U.K. and U.S. high-growth customer-centric brands and tech-enabled solutions across consumer sectors including beauty, health, wellness, family, lifestyle, nutrition, daily tech and modern commerce. Recent investments have included Maurten, a global sports nutrition company based in Sweden; Biomel, a plant-based gut health brand; and Superlativa, a drug- and hormone-free supplement that aims to help manage stress and regulate women's levels of cortisol. Best of WWD Harvey Nichols Sees Sales Dip, Losses Widen in Year Marred by Closures Nike Logs $1.3 Billion Profit, But Supply Chain Issues Persist Zegna Shares Start Trading on New York Stock Exchange Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data

RFK Jr. reconstituting vaccine advisory committee, retiring 17 current members
RFK Jr. reconstituting vaccine advisory committee, retiring 17 current members

Business Insider

time4 hours ago

  • Business Insider

RFK Jr. reconstituting vaccine advisory committee, retiring 17 current members

In an opinion article published by The Wall Street Journal, Robert F. Kennedy Jr. stated: 'Vaccines have become a divisive issue in American politics, but there is one thing all parties can agree on: The U.S. faces a crisis of public trust. Whether toward health agencies, pharmaceutical companies or vaccines themselves, public confidence is waning… That is why, under my direction, the U.S. Department of Health and Human Services is putting the restoration of public trust above any pro- or antivaccine agenda… Today, we are taking a bold step in restoring public trust by totally reconstituting the Advisory Committee for Immunization Practices (ACIP). We are retiring the 17 current members of the committee, some of whom were last-minute appointees of the Biden administration. Without removing the current members, the current Trump administration would not have been able to appoint a majority of new members until 2028… A clean sweep is needed to re-establish public confidence in vaccine science.' Confident Investing Starts Here:

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store